BELLUS Health Closes US$153 Million Public Offering of Common Shares in Canada and the United States Pharmaceutical Investing
Genmab Announces That AbbVie Will Submit Marketing Authorization Application to European Medicines Agency for Epcoritamab for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma Pharmaceutical Investing
Ginkgo Bioworks Announces Latest Collaboration for Beauty and Personal Care Industry with Sumitomo Chemical Life Science Investing
AbbVie Submits Marketing Authorization Application to EMA for Atogepant for the Preventive Treatment of Migraine Pharmaceutical Investing
Aurinia Announces the Addition of Three Seasoned Executive Leaders to Advance Company Strategy and Performance Pharmaceutical Investing
Clene Reports Significantly Decreased Mortality in RESCUE-ALS Long-Term Open Label Extension Trial Life Science Investing
BELLUS Health Announces Pricing of US$153 Million Public Offering in Canada and the United States Pharmaceutical Investing
